FDA Inspection
Adamson Analytical Laboratories, Inc.Adamson Analytical Laboratories, Inc. – FDA Inspection, Feb 10, 2017
Record Details
This FDA Inspection record concerns Adamson Analytical Laboratories, Inc., with an inspection on February 10, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 81f7ee4f-e3a9-4ed1-a1a4-d871e7fee6da
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1008998
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 211.194(d)Laboratory equipment calibration records
- 21 CFR 211.160(b)(4)Calibration - at intervals, written program, remedial action
- 21 CFR 211.22(c)Approve or reject procedures or specs
- 21 CFR 211.160(b)(4)Instruments, apparatus, et. al. not meeting specs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Adamson Analytical Laboratories, Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| September 12, 2024 | VAI | Los Angeles District Office | Drug Quality Assurance |
| October 4, 2022 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 23, 2021 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 14, 2015 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 7, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Adamson Analytical Laboratories, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.